Australia Restricts Risperidone Following Stroke Link


The Australian reports that their Therapeutic Goods Administration (TGA) received new data from drug company Janssen-Cilag, the developers of risperidone, “indicating a more than fivefold higher risk of ‘cerebrovascular adverse events’ — stroke or transient ischaemic ­attack — in patients with vascular or mixed dementia on risperidone.”

Article →


Support MIA

MIA relies on the support of its readers to exist. Please consider a donation to help us provide news, essays, podcasts and continuing education courses that explore alternatives to the current paradigm of psychiatric care. Your tax-deductible donation will help build a community devoted to creating such change.

Select Payment Method
Personal Info

Credit Card Info
This is a secure SSL encrypted payment.

Billing Details

Donation Total: $20 One Time


  1. This should not be surprising, as Risperdal and all the “atypical antipsychotics” cause heart issues in adults of whatever age. I’m glad Australia is finally doing something about it and hope the USA follows suit, but it should have been done long before. This is not new news.

    Report comment